Susquehanna International Group
IMMX icon

Susquehanna International Group’s Immix Biopharma IMMX Stock Holding History

Susquehanna International Group’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$237K Sell
26,000
-9,200
-26% -$67.6K ﹤0.01% 11371
2025
Q4 		$184K Buy
+35,200
New +$145K ﹤0.01% 10969

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Susquehanna International Group's IMMX Position: Q1 2026 in Review

Susquehanna International Group increased its Immix Biopharma (IMMX) stake by 20% in Q1 2026, buying an estimated $569K and bringing the position to 471,394 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4521.

Susquehanna International Group first reported a position in IMMX in Q1 2023 and has held it in 8 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Susquehanna International Group held 471,394 shares of Immix Biopharma worth $4.29M as of Q1 2026.
  • Susquehanna International Group bought 77,507 Immix Biopharma shares in Q1 2026, an estimated $569K.
  • Immix Biopharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4521 holding.
  • Susquehanna International Group first reported a position in Immix Biopharma in Q1 2023 and has held it in 8 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.